人类健康新闻

阅读针对膳食补充剂和婴儿配方产品的益生菌领域的最新消息。

想要了解更多信息？

Probiotics may help preterm infants
Press Release

Probiotics may help preterm infants

A new three-strain probiotic blend from Chr. Hansen can help support the health and development of intestines in preterm babies and has been shown to reduce risk of Necrotizing enterocolitis by 50%
As the dreaded flu-season knocks on our door, a new study reveals a secret weapon to reduce the cost of flu-like sickness
新闻稿

当可怕的流感爆发季节来临之际，一项新的研究发现了可以降低流感类疾病治疗成本的秘密武器

一项新的保健经济研究表明，摄入益生菌有助于降低流感类疾病的治疗成本。研究显示，如果服用益生菌，每年仅在美国就能减少超过 5,400 万天的病假。

Chr. Hansen in joint venture to accelerate momentum in microbiome
新闻稿

科汉森联合推进益生菌开发

科汉森联合推进益生菌开发。丹麦生物科技公司科汉森联合 Lonza AG 向新兴市场推出活性生物治疗产品

World’s best documented probiotic now available for fermented plant bases
新闻稿

全球文献记录最完备的益生菌现在可用于发酵植物

科汉森推出 nu-trish® LGG® DA 以进一步提升发酵植物的健康品味
Chr. Hansen reaches major milestone in innovation pipeline
新闻稿

科汉森在创新方面实现重要的里程碑

临床试验表明，对于常规使用的家用止痛药造成的内脏损伤，益生菌能够加强防御
文章 | May 13, 2019

《胃肠病学》(Gastroenterology) 杂志发布科汉森临床试验成果

精选新型益生菌菌株临床试验的成果发布是科汉森的首创以及朝着新型膳食补充剂商业化的重要一步
New partnership to develop treatment for peanut allergies
新闻稿

开发花生过敏疗法的新合作关系

食物过敏口服免疫药物开发商Prota Therapeutics公司已与科汉森达成合作。在合作期间，双方将在III期临床试验中对全球文献记录最完备的益生菌菌株LGG®进行评估，以开发花生过敏疗法。
新闻 | 2018 年 4 月 9 日

人类健康业务的新任领导将带领团队进军极具吸引力的增长市场

Andrew Scorey 拥有 25 年的消费者保健行业经验，他将加入科汉森并担任人类健康业务的高级副总裁。
文章 | February 19, 2018

科汉森推出新的LGG®网站

致力于展示世界有记录的最佳益生菌菌株-鼠李糖乳杆菌（LGG®）新网站向您解释 LGG® 菌株为什么是膳食补充剂，婴儿配方奶粉和发酵乳制品的最佳选择的科学建议。
Microbiome is our next generation of probiotics

Microbiome is our next generation of probiotics

New and exciting opportunities are emerging in
this breakthrough area
文章 | July 5, 2017

100种全新的下一代益生菌候选菌种

将开创性的科学技术转化为新的微生物解决方案，改善保健，预防或治疗疾病
Lactobacillus rhamnosus (LGG®) - the world's best documented probiotic strain

Lactobacillus rhamnosus (LGG®)

An introduction to the world's best documented probiotic strain.
文章 | March 31, 2017

妇女泌尿生殖健康益生菌研讨会

你知道有些益生菌可能有益于女性泌尿生殖系统的健康吗？

文章 | March 17, 2017

研究表明，益生菌可能有助于携带有B组链球菌(GBS)群落的孕妇

本研究调查了鼠李糖乳杆菌(GR-1)和罗伊氏乳杆菌(RC-14®)对携带有B组链球菌(GBS)群落的孕妇的影响。
To further strengthen its probiotics offering Chr. Hansen acquires LGG®, the world’s best documented probiotic strain, from Valio OY
新闻稿

为进一步加强其益生菌产品，科汉森从 Valio OY 收购了全球文献记录最完备的益生菌菌株 LGG®

对于促进人类健康的天然解决方案的需求极大，行业内的微生物解决方案的预期增长率为 7-9%。科汉森是全球领先的用于膳食补充剂、婴儿配方食品和乳制品的益生菌供应商。现在，通过收购 LGG® 业务，公司正进一步加强其所有三个类别的微生物平台。
文章 | June 17, 2016

科汉森在2016年IPC上展出益生菌最新研究成果

在2016年6月21-23日在匈牙利布达佩斯举办的IPC（国际益生菌和益生元科学研讨会）上，人类健康发现(Human Health Discovery)部门的首席科学家Thomas D. Leser展示了关于我们的一些最新的益生菌研究海报。
See how our probiotic drops are made

See how our probiotic drops are made

Our probiotic drops are a convenient solution for infants and young children - safe, easy to dose and can be stored at room temperature (25°).
We offer: insight, invention, integrity
视频

我们提供：洞察力、创造力和诚信

我们的 3I 原则描述了我们的工作方式和我们提供的产品/服务。
Our 3 USPs - it works, it lasts, it's different

Our 3 USPs - it works, it lasts, it's different

Add value to your brand with Probio-Tec® probiotics.
Hear Eric Johansen talk about Bifidobacterium (BB-12®)

Hear Eric Johansen talk about Bifidobacterium (BB-12®)

The BB-12® probiotic strain was introduced to the market in 1985. Today approx. 200 million people eat products, containing this particular probiotic strain. Eric Johansen is Associate Vice President, Science, at Chr. Hansen.
Chr. Hansen enters first collaboration on production of a next generation probiotic from the Human Microbiome
Press Release

Chr. Hansen enters first collaboration on production of a next generation probiotic from the Human Microbiome

Today, Chr. Hansen and Caelus Health announce their collaboration on the development of Eubacterium hallii as a next generation probiotic for prevention and treatment of metabolic disease.
One of the world's largest clinical studies on probiotics reinforces significant gastrointestinal benefits of the probiotic strain named BB-12®
Press Release

One of the world's largest clinical studies on probiotics reinforces significant gastrointestinal benefits of the probiotic strain named BB-12®

Millions of people around the world suffer from a range of gastrointestinal symptoms. Results from one of the world’s largest clinical studies on probiotics now show that the probiotic strain named BB-12® can be part of the solution by improving bowel regularity.
New study confirms presence of bifidobacteria and lactobacilli in breast milk from Chinese mothers
Press Release

New study confirms presence of bifidobacteria and lactobacilli in breast milk from Chinese mothers

​A study initiated by Chr. Hansen has shown that bifidobacteria and lactobacilli are present in breast milk from Chinese mothers, strengthening the case for adding clinically documented probiotics to infant formula, in order to improve nutrition.
Chr. Hansen accelerates efforts within human microbiome
Press Release

Chr. Hansen accelerates efforts within human microbiome

Establishes a new research and development consortium and secures access and commercialization rights to an important resource of strains
新闻 | September 4, 2015

饮料益生菌

饮料益生菌 - 了解更多有关L. CASEI 431® Juice的信息

共享